Search

everythinglearnresearchcommunity

for

Search:↓

Mutations in the SRD5A3 gene cause a new type of glycosylation disorder by blocking the production of a molecule necessary for protein glycosylation.

The document reports three sisters with Woodhouse-Sakati syndrome showing typical symptoms and unusual gynecological anomalies.

Certain genetic changes in the LSS gene cause a rare skin and hair condition.

A protein called GIS3 is important for the growth of root hairs in Arabidopsis by controlling two genes with the help of certain growth signals.

ATR04-484 ointment shows promise for treating skin issues from cancer therapies.

The American Society of Hair Restoration Surgery (ASHRS) is a group focused on improving hair restoration methods.

Blocking certain receptors in the lungs might help treat a specific type of asthma.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

The 6-year-old Somalian girl fully recovered from her symptoms after successful surgery and treatment.

Astrotactin2 affects hair follicle orientation and skin cell polarity.

A mutant FERONIA gene affects root hair growth at high temperatures.

No link found between specific genes and female pattern hair loss.

FERONIA regulates plant growth, pollen interactions, and sugar signaling.

Stereotactic Radiosurgery is an effective non-invasive treatment for cerebral AVM, with successful outcomes and minimal side effects.

Ablative CO2 laser resurfacing tightens skin by destroying and regenerating skin layers.

Elf5 controls skin cell growth and development, making it a potential target for skin treatments.

A new genetic change in the DSC3 gene is linked to a rare condition causing hair loss and skin blisters in a child.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

The document's conclusion cannot be determined.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

The patient has a rare skin condition that shows features of two known disorders.

The condition might be caused by genetic changes after birth.

New compounds were made that are promising for prostate cancer therapy.

The same genetic mutation in Sjögren-Larsson syndrome can lead to different levels of severity, suggesting other factors influence the symptoms.

A certain smell receptor in hair follicles can affect hair growth when activated by a synthetic sandalwood scent.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.